Physicians’ perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|47|6|773-783

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.47, Iss.6, 2018-03, pp. : 773-783

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytokines in inflammatory bowel disease

By Beck P. L.   Wallace J. L.  

Mediators of Inflammation, Vol. 6, Iss. 2, 1997-04 ,pp. : 95-103

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory bowel disease in Asia

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 3, 2010-03 ,pp. : 436-438

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inflammatory Bowel Disease

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. S3, 2015-09 ,pp. : 117-148

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rationale for the use of rifaximin in inflammatory bowel diseases based on clinical trial results

By Lorenzetti Roberto   Prantera Cosimo  

Clinical Investigation, Vol. 3, Iss. 12, 2013-12 ,pp. : 1187-1193

Future Science

Access to resources Recommend Favorite

Recent Advances in Inflammatory Bowel Disease

By Farrell Richard J.   Banerjee Subhas   Peppercorn Mark A.  

Critical Reviews in Clinical Laboratory Sciences, Vol. 38, Iss. 1, 2001-01 ,pp. : 33-108

Informa Healthcare

Access to resources Recommend Favorite